Latanoprost in hypotensive therapy of glaucoma

Vestnik oftalmologii
V P Erichev, V S Zinina

Abstract

The review presents an analysis of therapeutic effectiveness, safety and pharmacokinetics of latanoprost - the reference representative of the prostaglandin group, summarizes the experience of its clinical use in glaucoma as monotherapy and in combination with antihypertensive drugs of other pharmacological groups, its possible effect on the inflammatory process in the anterior segment of the eye, as well as its probable participation in the development of macular edema. The article also gives a recount of relevant local and systemic adverse events.

References

Mar 4, 2000·Japanese Journal of Ophthalmology·M SuzukiI Azuma
Mar 22, 2000·Acta Ophthalmologica Scandinavica·A Alm, I Widengård
Jul 5, 2001·American Journal of Ophthalmology·J MoralesM R Hodges
Sep 27, 2001·Advances in Therapy·S GandolfiUNKNOWN Bimatoprost Study Group 3
Oct 6, 2001·BMJ : British Medical Journal·M MitraT James
Oct 9, 2001·American Journal of Ophthalmology·P A NetlandUNKNOWN Travoprost Study Group
Sep 3, 2002·Survey of Ophthalmology·Birgitta Sjöquist, Johan Stjernschantz
Sep 3, 2002·Survey of Ophthalmology·Murray A Johnstone, Daniel M Albert
Sep 12, 2002·Clinical Pharmacokinetics·Jane Alcorn, Patrick J McNamara
Feb 25, 2003·The British Journal of Ophthalmology·I C LaiL M C Teng
Mar 5, 2003·American Journal of Ophthalmology·William C StewartAngi L Jackson
Mar 5, 2003·American Journal of Ophthalmology·David J BrowningKurt K Lark
Mar 22, 2003·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Robert M Feldman
Jun 11, 2003·Drugs & Aging·Caroline M PerryTim Ibbotson
Oct 1, 2003·American Journal of Ophthalmology·Punita Kumari Sodhi
Oct 2, 2003·Journal of Glaucoma·James C TsaiJames W Pichert
Jul 14, 2004·Archives of Ophthalmology·Albert AlmJacquie McDermott
Aug 10, 2004·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Lee S Peplinski, Karen Albiani Smith
Sep 9, 2004·Journal of Glaucoma·Gerald BeanThom J Zimmerman
Oct 19, 2004·American Journal of Ophthalmology·Esther Arranz-MarquezRaquel Gil
Nov 4, 2004·Journal of the American Academy of Dermatology·Joseph W Burnett, Valerie M Harvey
Nov 10, 2004·Archives of Ophthalmology·Daniel M AlbertW Richard Green
Dec 14, 2004·Japanese Journal of Ophthalmology·Ian GriersonKathryn Cracknell
Apr 6, 2005·American Journal of Ophthalmology·Vassilios P KozobolisAnastasios G Konstas
Jul 11, 2006·The British Journal of Ophthalmology·L B CantorUNKNOWN Bimatoprost-Travoprost Study Group
Dec 13, 2006·American Journal of Ophthalmology·Marco CentofantiGianluca Manni
Dec 22, 2006·Expert Opinion on Drug Safety·Gábor Holló
Sep 8, 2007·Acta Ophthalmologica Scandinavica·Viney GuptaRamanjit Sihota
May 6, 2008·Klinische Monatsblätter für Augenheilkunde·C TappeinerD Goldblum
Jul 23, 2008·Ophthalmic Plastic and Reconstructive Surgery·Theodoros FilippopoulosCynthia L Grosskreutz
Dec 17, 2008·Survey of Ophthalmology·Albert AlmM Bruce Shields
Apr 1, 2009·Japanese Journal of Ophthalmology·Hee Kyung YangDong Myung Kim
May 30, 2009·Pharmacotherapy·Gail D Anderson, Anne M Lynn
Oct 28, 2009·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Jason C S YamClement W N Chan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.